Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad Q3 Revenues Rise 8 Percent as Profit Surges 43 Percent

NEW YORK (GenomeWeb News) — Bio-Rad Laboratories today said third-quarter revenues increased 8 percent as R&D spending rose 8 percent and profit increased 43 percent.
Total receipts for the three months ended Sept. 30 increased to $305 million from $283 million year over year.
Revenue from the company’s Life Science division was up 4 percent to $137 million from $132 million while receipts from the Clinical Diagnostics segment jumped 11 percent to $164 million from $148 million year over year.
Bio-Rad said increased sales in Life Science came from first orders of its new Protein Array Interaction System, and the growth in its Clinical Diagnostics was “across all product lines.”
R&D spending increased to $31 million from $29 million year over year.
The company said third-quarter profit increased to $23.1 million from $16.2 million in the year-ago period.
Bio-Rad said it had around $481.5 million in cash, cash equivalents, and short-term investments as of Sept. 30.
Yesterday, GenomeWeb News reported that Bio-Rad’s impending acquisition of Ciphergen’s proteomics tool business has been delayed. In a statement, Bio-Rad said the acquisition "is in the process of being completed."

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.